| ID | 1564 |
|---|
| No | 1564 |
|---|
| Brand Name | ZETRO CAPSULE 250 MG |
|---|
| Ingredients | AZITHROMYCIN (AS DIHYDRATE) 250 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | ALU-ALU |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 1X 10'S/BOX |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | ZETRO (AZITHROMYCIN ) IS INDICATED FOR THE TREATMENT OF PATIENTS WITH MILD TO MODERATE INFECTIONS CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICRO-ORGANISMS IN THE SPECIFIC LISTED: LOWER AND UPPER RESPIRATORY INFECTION, UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, SEXUALLY TRANSMITTED DISEASE. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | HARD GELATIN CAPSULE WITH LIGHT BLUE OPAQUE CAP AND WITH OPAQUE BODY CONTAINING WHITE GRANULAR POWDER |
|---|
| Note | |
|---|
| License Owner | LAO INTER PHARMA CO.,LTD |
|---|
| Manufacturer | GETZ PHARMA (PRIVATE) LIMITED |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 I 4112/15 |
|---|
| FDD Registration Date | 10/02/2023 |
|---|
| Expiry Date | 09/02/2026 |
|---|
